Home Industry Reports Custom Research Blogs About Us Contact us

Compounding Pharmacies Market Size & Share, By Therapeutic Area (Specialty Drugs, Dermatology), Age Cohort (Pediatric, Adult), Compounding Type (PIA, PDA), Sterility, Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Report ID: FBI 5937

|

Published Date: Aug-2024

|

Format : PDF, Excel

التوقعات السوقية:

Compounding Pharmacies Market crossed USD 13.23 Billion in 2023 and is expected to exceed USD 20.88 Billion by end of the year 2032, observing around 5.2% CAGR between 2024 and 2032.

Base Year Value (2023)

USD 13.23 Billion

19-23 x.x %
24-32 x.x %

CAGR (2024-2032)

5.2%

19-23 x.x %
24-32 x.x %

Forecast Year Value (2032)

USD 20.88 Billion

19-23 x.x %
24-32 x.x %
Compounding Pharmacies Market

Historical Data Period

2019-2023

Compounding Pharmacies Market

Largest Region

North America

Compounding Pharmacies Market

Forecast Period

2024-2032

Get more details on this report -

سوق الديناميكية:

Growth Drivers & Opportunity:

The increasing prevalence of chronic diseases and the growing geriatric population are major growth drivers for the compounding pharmacies market. As the demand for personalized medication tailored to individual patient needs continues to rise, compounding pharmacies are poised to experience significant growth in the coming years. Additionally, the rising adoption of compounding services by physicians and patients is expected to drive market expansion.

Report Scope

Report CoverageDetails
Segments CoveredTherapeutic Area, Age Cohort, Compounding Type, Sterility
Regions Covered• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company ProfiledWalgreens Co, JL Diekman and AQ Touchard, Fagron, Albertsons Companies, The London Specialist Pharmacy., Galenic Laboratories., Aurora Compounding MEDS Pharmacy, Apollo Clinical Pharmacy, Formul8, Fusion Apothecary

Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!

Industry Restraints:

Stringent regulatory requirements and the lack of standardized guidelines are key restraints for the compounding pharmacies market. The complex regulatory landscape poses challenges for compounding pharmacies in terms of compliance and may hinder market growth. Moreover, the absence of clear guidelines for compounding practices can lead to quality issues, creating barriers for market expansion.

التوقعات الإقليمية:

Compounding Pharmacies Market

Largest Region

North America

44% Market Share in 2023

Get more details on this report -

North America:

The compounding pharmacies market in North America is the largest globally, with the United States leading in terms of market share. The market is driven by the increasing demand for personalized medications and the growing prevalence of chronic diseases. Canada also plays a significant role in the market, with an increasing number of compounding pharmacies catering to the needs of the population.

Asia Pacific:

The compounding pharmacies market in Asia Pacific is experiencing rapid growth, especially in countries like China, Japan, and South Korea. This can be attributed to the rising healthcare expenditure, increasing awareness about personalized medicine, and the presence of a large geriatric population. China, in particular, is witnessing a surge in the number of compounding pharmacies due to the government's initiatives to promote the use of traditional Chinese medicine.

Europe:

In Europe, countries like the United Kingdom, Germany, and France are witnessing a steady growth in the compounding pharmacies market. The increasing healthcare expenditure, rising prevalence of chronic diseases, and the growing demand for customized medications are driving the market in these regions. The United Kingdom, in particular, is experiencing a significant increase in the number of compounding pharmacies, with a focus on providing high-quality, personalized medications to patients.

Report Coverage & Deliverables

Historical Statistics Growth Forecasts Latest Trends & Innovations Market Segmentation Regional Opportunities Competitive Landscape
Compounding Pharmacies Market
Compounding Pharmacies Market

تحليل التجزئة:

""

In terms of segmentation, the global Compounding Pharmacies market is analyzed on the basis of Therapeutic Area, Age Cohort, Compounding Type, Sterility.

1. Therapeutic Area

Specialty Drugs:

The compounding pharmacies market in the specialty drugs segment is expected to witness steady growth due to the increasing demand for personalized medications to treat complex and rare conditions. These medications are often not readily available in standard forms, leading patients to seek custom compounded solutions from specialty compounding pharmacies.

Dermatology:

The dermatology segment of the compounding pharmacies market size is anticipated to experience significant growth as more consumers seek customized medications for skin conditions such as eczema, psoriasis, and acne. Compounded dermatological products offer patients personalized treatment options that may not be available in commercially manufactured formulations.

2. Age Cohort

Pediatric:

Compounding pharmacies play a crucial role in providing customized medications for pediatric patients who may have difficulty swallowing pills or require specific dosage forms based on their age and weight. The pediatric segment of the compounding pharmacies market is expected to expand due to the growing demand for tailored medications for children with unique healthcare needs.

Adult:

The adult segment of the compounding pharmacies market is projected to grow as more adults seek personalized medications for chronic conditions, hormone replacement therapy, and pain management. Compounded medications offer adults the flexibility to receive custom dosage strengths and formulations tailored to their individual health requirements.

3. Compounding Type

PIA:

Point-of-care compounding, also known as PIA (Pharmacy In Aseptic), allows pharmacists to prepare sterile medications on-site for immediate administration to patients. The PIA segment of the compounding pharmacies market size is anticipated to grow as healthcare facilities increasingly adopt aseptic compounding practices to ensure medication safety and efficacy.

PDA:

Prepared dosage adaptation, or PDA, involves customizing medications to suit individual patient needs based on factors such as allergies, intolerances, and preferences. The PDA segment of the compounding pharmacies market is poised for growth as more patients seek personalized treatment options that address their unique healthcare requirements.

4. Sterility

The sterility segment of the compounding pharmacies market focuses on ensuring the safety and efficacy of compounded medications by adhering to stringent sterilization protocols. As healthcare facilities and patients prioritize infection control measures, the demand for sterile compounded products is expected to rise, driving growth in the sterility segment of the compounding pharmacies market.

Get more details on this report -

مشهد تنافسي:

The compounding pharmacies market is characterized by a diverse range of players, from small, independent pharmacies to larger, well-established companies. The increasing demand for personalized medicine and specialized formulations has intensified competition within this sector. Technological advancements, such as automation and quality assurance systems, have allowed these pharmacies to improve efficiency and minimize errors in drug preparation, thereby enhancing their competitive edge. Regulatory compliance and adherence to quality standards play crucial roles in determining market position, as consumers increasingly prioritize safety and efficacy in compounded medications. The market is witnessing consolidation trends, with larger firms acquiring smaller compounding pharmacies to expand their service offerings and geographic reach, thus intensifying the competitive dynamics.

Top Market Players

- Fagron

- Neomedic

- PharMEDium Services

- Custom Compounding

- Wellpartner

- B. Braun Melsungen AG

- Wedgewood Pharmacy

- APC Pharmacy

- Compounding Pharmacy of America

- Pencol Compounding Pharmacy

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Compounding Pharmacies Market Size & Share, By The...

RD Code : 24